21 Comments
 

IMO these are all comparable names more or less. Some hardos might prefer Moelis over the others while people who want a more chill environment will opt for PWP for example

 

Any EB will get you great looks for PE/buyside shops (with obvious outlier groups like PJT RSSG/EVR RX). At a super high level though: Don't go to Moelis if you want to have a life (but you will have stellar exits and get lots of reps in)... EVR RX/M&A obviously stellar all around with top pay... PWP top culture/pay with great exits... PJT M&A is a tier below RSSG but still great exits albeit a sweatshop... LAZ is honestly just questionable now with departures and downtrend in performance... GHL will likely continue going downhill

 

PJT RSSG (consensus no. 1 rx group) > MOE RX (great traction and impressive mandates) > LAZ RX (lost too many seniors) > PWP RX (too small IMO and dealflow is fluctuating AFAIK)

 

What are you talking about?

PWP beat HL this year for Creditor advisory mandates +a couple big time debtor side mandates. PIMCO literally switched advisors from Evercore to PWP for iheart…
 

its more like PJT>PWP/Moelis>> Lazard. We pitched against Lazard (I’m at another EB) and they won the advisory by slashing their fees. Not the best look.

 

curious to know why PWP is considered worse (not working there)? Saw them on some pretty big deals this year and their average deal size is probably higher than Moelis or Lazard

 

How does average deal size matter? Perella has higher average deal size than for eg Moelis yet at my target people would take Moelis 9/10. Perella simply hasn't been consistent enough to really be placed with the other top EBs (CVP, EVR, MOE, and PJT).  

 

Quae eaque consequuntur mollitia error. Veritatis doloribus sunt dignissimos consectetur amet facilis voluptatibus reiciendis.

Culpa dicta et unde fuga quis. In voluptatibus earum atque. Corrupti dolor maiores autem aliquam dolore qui et. Veritatis hic quibusdam esse voluptas. Provident dolor mollitia sint eum quia. Quas eligendi autem ea magnam. Culpa qui at et voluptas.

Career Advancement Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Goldman Sachs 01 97.9%
  • Morgan Stanley 07 97.3%

Overall Employee Satisfaction

September 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 03 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 07 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.3%

Total Avg Compensation

September 2026 Investment Banking

  • Vice President (16) $429
  • Associates (51) $260
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (26) $182
  • Intern/Summer Associate (15) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”